Moderna on X: "A 50 µg #booster dose of our first bivalent booster #vaccine candidate, mRNA-1273.211, demonstrated superiority against Beta, Delta and #Omicron variants of concern one month after administration, and superiority
Second bivalent COVID-19 booster vaccine from Moderna (Spikevax) authorised by UK medicines regulator - GOV.UK
New Moderna and Pfizer-BioNTech Bivalent COVID-19 Boosters Available at Meharry | Meharry Medical Group